Curcumin
- Generic Name
- Curcumin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C21H20O6
- CAS Number
- 458-37-7
- Unique Ingredient Identifier
- IT942ZTH98
- Background
Curcumin, also known as diferuloylmethane, is an active component in the golden spice turmeric (Curcuma longa) and in Curcuma xanthorrhiza oil. It is a highly pleiotropic molecule that exhibits antibacterial, anti-inflammatory, hypoglycemic, antioxidant, wound-healing, and antimicrobial activities . Due to these properties, curcumin has been investigated for...
- Indication
No approved therapeutic indications.
- Associated Conditions
- -
- Associated Therapies
- -
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
- First Posted Date
- 2018-12-10
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 291
- Registration Number
- NCT03769766
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Curcumin and Vascular and Cognitive Function in Patients With Chronic Kidney Disease
- Conditions
- Interventions
- First Posted Date
- 2017-07-21
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Diana Jalal
- Target Recruit Count
- 94
- Registration Number
- NCT03223883
- Locations
- 🇺🇸
University of Iowa, Iowa City, Iowa, United States
Curcumin and Function in Older Adults
- Conditions
- Interventions
- First Posted Date
- 2017-03-21
- Last Posted Date
- 2022-07-26
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 17
- Registration Number
- NCT03085680
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
"Curcumin" in Combination With Chemotherapy in Advanced Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2017-03-08
- Last Posted Date
- 2019-11-27
- Lead Sponsor
- National Center of Oncology, Armenia
- Target Recruit Count
- 150
- Registration Number
- NCT03072992
- Locations
- 🇦🇲
National Center of Oncology, Yerevan, Armenia
A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC)
- First Posted Date
- 2016-11-30
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- John E. Eaton
- Target Recruit Count
- 15
- Registration Number
- NCT02978339
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Topical Curcumin for Precancer Cervical Lesions
- First Posted Date
- 2016-10-26
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Lisa Flowers
- Target Recruit Count
- 7
- Registration Number
- NCT02944578
- Locations
- 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
🇺🇸Grady Hospital - Ponce De Leon Clinic, Atlanta, Georgia, United States
Glutathione vs. Curcumin Clinical Trial
- First Posted Date
- 2016-07-28
- Last Posted Date
- 2020-01-29
- Target Recruit Count
- 75
- Registration Number
- NCT02848417
- Locations
- 🇺🇸
Miami VA Center, Miami, Florida, United States
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia
- Conditions
- Interventions
- First Posted Date
- 2016-05-26
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 50
- Registration Number
- NCT02782949
- Locations
- 🇭🇳
Hospital Regional de Occidente, Santa Rosa De Copan, Honduras
🇵🇷University of Puerto Rico, San Juan, Puerto Rico
Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT)
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2017-10-12
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 64
- Registration Number
- NCT02724618
- Locations
- 🇮🇷
Shohada-e-Tajrish Medical Center, Tehran, Iran, Islamic Republic of
Curcumin in Combination With 5FU for Colon Cancer
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- Baylor Research Institute
- Target Recruit Count
- 13
- Registration Number
- NCT02724202
- Locations
- 🇺🇸
Baylor Charles A. Sammons Cancer Center, Dallas, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.